Related Experiment Videos
Sarcomas involving the abdominal and pelvic cavity
V Fernández-Trigo1, P H Sugarbaker
1Cancer Institute, Washington Hospital Center, Washington, DC.
Tumori
|April 30, 1993
Summary
Complete surgical resection is the primary treatment for abdominal and pelvic sarcomas. Systemic therapies like chemotherapy and radiotherapy have limited efficacy, making surgical expertise crucial for successful management of these rare cancers.
Area of Science:
- Surgical Oncology
- Abdominal and Pelvic Cancer Management
- Sarcoma Research
Background:
- Sarcomas involving the abdominal and pelvic cavity present unique management challenges.
- Primary sites include retroperitoneal, pelvic sidewall, visceral, and pelvic organ sarcomas.
- Histologic diversity necessitates a unified approach to therapeutic options.
Purpose of the Study:
- To outline the principles of managing abdominal and pelvic sarcomas.
- To emphasize the critical role of surgical intervention.
- To review the limited efficacy of systemic therapies.
Main Methods:
- Focus on surgical principles for sarcoma management.
- Discussion of therapeutic options across all histologic types.
- Emphasis on anatomical knowledge, surgical skill, and innovation.
Main Results:
- Complete surgical resection with adequate margins is the principal goal.
- Systemic chemotherapy and radiotherapy have not demonstrated reproducible efficacy.
- Complete resection without tumor spillage is the only reliable curative treatment.
Conclusions:
- Surgical expertise is paramount for curative treatment of abdominal and pelvic sarcomas.
- Adjuvant or neoadjuvant chemotherapy, including intraperitoneal approaches, may offer potential benefits.
- Further research into optimizing multimodal treatment strategies is warranted.